Skip to content

AVA-ROSE

Active
Private limited companyfounded 20251 yr activeBurgemeester J-L Thysplein 1B, 1090 Jette, BelgiumKBO/BCE: BE 1022.725.141
Summary

The computed 12-month bankruptcy probability of AVA-ROSE is 2.6% (moderate). The 2025 annual accounts show negative equity (-€2,001) and a net result of -€3,001. Its solvency ranks better than 22% of 21069 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 2 administrative register entries (see administrative flags).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€381,859total assets 2025
Staff
0.8 FTE
Equity
-€2,001
Loss
-€3,001
Turnover not published (abridged schema)
Financial health
51 Fair Checked score 2025
Bankruptcy chance 12 m
2.6%
Structure
Accounts 30 d early0 of 1 deed read
Why 51- 2 ex-officio strike-offs in the KBO- Founded in 2025- Negative equity -€2,001+ Size: total assets €381,859Show the evidence

Checked score

Score 2025
51 / 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 30% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Financial strength
Weak
Solvency 24
equity -0.5% of total assets
Liquidity 45
short-term debt 42.9% · cash 12.7%
Profitability 37
return on assets -0.8%
Bankruptcy probability, 12 months
2.6% Moderate
0%0.5%1.5%4%10%≥ 25%

About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.7% (39,919 companies)
Last 24 months 05-2026: 4.0% 06-2026: 4.0%● 0.0% vs 05-2026 07-2026: 4.1%▲ +4.6% vs 06-2026highest value 08-2026: 2.6%▼ -37.9% vs 07-2026lowest value 09-2026: 2.6%● 0.0% vs 08-2026lowest value 10-2026: 2.6%▲ +1.7% vs 09-2026
  • Size: total assets €381,859 lowers the probability for this profile
  • 2 ex-officio strike-offs in the KBO raises the probability
  • Founded in 2025 raises the probability for this profile
  • Negative equity -€2,001 raises the probability
No credit on open account
Liquidity short (current ratio 0.97; short-term debt: 42.9% and cash: 12.7% of total assets), and equity is negative.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 19%, liquidity 44%, profitability 28%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €381,859
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
raises risk · 2 ex-officio strike-offs in the KBO
In the bankruptcy model this factor raises the probability.
KBO publications
raises risk · Founded in 2025
In the bankruptcy model this factor raises the probability for this profile.
KBO
raises risk · Negative equity -€2,001
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
30 d early
← before the deadline after the deadline →
raises risk · Administrative warnings in the KBO publications
2 publications by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or their withdrawal.
KBO publications
Publications
UBO non-compliance×2
  1. Annual accounts filedfiscal year 2025 · micro…
  2. UBO non-complianceevent 24-11-2025
  3. UBO non-complianceevent 22-10-2025

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€2,001 View
  • Founded 17 months agofounded 25-04-2025 17 mo View
  • Total assets 2025first fiscal year filed €381,859 View

By topic

Financials

Fiscal year
2025
Total assets
€381,859
Loss
-€3,001
Solvency
-0.5%
Go to Financials

Timeline

Events
3
Since
2025
  1. 01-07-2026Annual accounts filed
  2. 05-12-2025UBO non-compliance
  3. 31-10-2025UBO non-compliance
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
25-04-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.